The Nonsteroidal Farnesoid X Receptor (Fxr) Agonist Cilofexor Improves Liver Biochemistry in Patients With Primary Biliary Cholangitis (Pbc): A Phase 2, Randomized, Placebo-Controlled Trial
Journal article published in 2019 by
Kris Kowdley,
Gerald Y. Minuk,
Mangesh R. Pagadala,
Aliya Gulamhusein,
Mark Gordon Swain,
Guy W. Neff,
Donald Zogg,
Christopher L. Bowlus,
Kosh Agarwal 
,
Eric M. Yoshida,
Yao Li,
Georgia Li,
Chuhan Chung,
Mani Subramanian,
Robert P. Myers
and other authors.
,
Eric M. Yoshida,
Yao Li,
Georgia Li,
Chuhan Chung,
Mani Subramanian,
Robert P. Myers
and other authors.
